T. Rowe Price Investment Management, Inc. Prime Medicine, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

$162 Billion
Q4 2024

A detailed history of T. Rowe Price Investment Management, Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,977,828 shares of PRME stock, worth $11.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,977,828

Previous 3,807,287 4.48%

Holding current value

$11.8 Million

Previous $14.7 Million 21.17%

% of portfolio

0.01%

Previous 0.01%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.64 - $4.46 $450,228 - $760,612	170,541 Added 4.48%	3,977,828 $11.6 Million
Q3 2024 Nov 14, 2024	BUY	$3.41 - $6.7 $278,119 - $546,452	81,560 Added 2.19%	3,807,287 $14.7 Million
Q2 2024 Aug 14, 2024	BUY	$4.3 - $8.03 $2.73 Million - $5.1 Million	635,644 Added 20.57%	3,725,727 $19.2 Million
Q1 2024 May 15, 2024	BUY	$6.35 - $9.39 $19.6 Million - $29 Million	3,090,083 New	3,090,083 $21.6 Million

Others Institutions Holding PRME

# of Institutions

136

Shares Held

60.9M

Call Options Held

42.6K

Put Options Held

173K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $284M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Account

T. Rowe Price Investment Management, Inc. Prime Medicine, Inc. Transaction History